Telios Pharma
1 known investors
Find your way into Telios Pharma
Telios Pharma is a clinical-stage biopharmaceutical company developing first-in-class topical and oral BTK-inhibitor drugs targeting mast-cell-mediated inflammation, including TL-925 for dry eye disease.
Investors · 1
Frequently asked questions
- What does Telios Pharma do?
- Telios Pharma is a clinical-stage biopharmaceutical company developing first-in-class topical and oral BTK-inhibitor drugs targeting mast-cell-mediated inflammation, including TL-925 for dry eye disease.
- Who are Telios Pharma's investors?
- Telios Pharma's investors include SR One Capital Management.